Sissetulev kiriAvalik
Farmakopöa tööplaani asjus
Ravimiamet · 17. mai 2024
- Viit
- REP-1/1808-1
- Registreeritud
- 17. mai 2024
- Dokumendi liik
- Sissetulev kiri
- Adressaat
- European Directorate for the Quality of Medicines & HealthCare
- Saabumis/saatmisviis
- e-post
- Funktsioon
- REP Euroopa Farmakopöaga seotud asjaajamine
- Sari
- REP-1 Euroopa Farmakopöa alane kirjavahetus
- Toimik
- REP-1/2024
- Vastutaja
- Signe Leito (RA, Labor)
Sisu (failidest)
Signe Leito
Saatja: [email protected]
Saatmisaeg: kolmapäev, 10. aprill 2024 13:39
Adressaat: Signe Leito
Teema: Proposed addition to the work programme P4: Vismodegib and Vismodegib capsules: EDQM-2024-01508-mail
Tähelepanu! Tegemist on väljastpoolt asutust saabunud kirjaga. Tundmatu saatja korral palume linke ja faile mitte avada.
Please make sure to include in any reply our mail reference: EDQM-2024-01508-mail
****************************************************************************
For the attention of: NPAs
Copy: Presidium
Dear Colleagues,
Please find below the link to a survey being carried out concerning the proposed addition of two monographs to the work programme of Group P4:
https://survey.edqm.eu/index.php?r=survey/index&sid=187384&newtest=Y&lang=en
- Vismodegib
- Vismodegib capsules
Deadline for replies: 20 May 2024
With kind regards,
On behalf of Monica Sorinas Jimeno
Villy Nikolova
Administrative Support Assistant
European Pharmacopoeia Department
EDQM
Council of Europe
Tel.: +33 (0)3 90 21 64 63 / Fax: +33 (0)3 88 41 27 71
https://www.edqm.eu / https://www.edqm.eu/store
Stay connected with the EDQM
1
****************************************************************************
Please make sure to include in any reply our mail reference: EDQM-2024-01508-mail
2